ACell Inc is a United States-based company that provides wound management solutions. The Company offers a range of products, including Cytal Burn Matrix, which is a medical device used for the management of second degree burns; Cytal Wound Matrix, which is are used for acute wounds and chronic wounds; Gentrix Surgical Matrix, which is used in a range of surgical procedures, including various types of hernia repair, and MicroMatrix, which is used for acute wounds and chronic wounds. The Company uses MatriStem UBM (Urinary Bladder Matrix) technology for the manufacturing of Gentrix, Cytal, and MicroMatrix product lines.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Delayed Nasdaq Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-

20/01/21	Integra LifeSciences Holdings Corporation completed the acquisition of ACell, Inc for approximately $410 million.	CI
22/12/20	ACell, Inc. Announces CE Mark Approval	CI

20/01/21	Integra LifeSciences Holdings Corporation completed the acquisition of ACell, Inc for approximately $410 million.	CI
22/12/20	ACell, Inc. Announces CE Mark Approval	CI
16/12/20	Integra LifeSciences Holdings Corporation entered into a definitive agreement to acquire ACell, Inc. for $400 million.	CI
20/07/20	ACell, Inc. has withdrawn its IPO in the amount of $80 million.	CI
26/06/20	ACell, Inc. has filed an IPO in the amount of $86.25 million.	CI
05/09/19	ACell, Inc. Announces Launch of their New Product, Gentrix Hiatal at the 2019 Society of Laparoendoscopic Surgeons Minimally Invasive Surgery Week 2019 in New Orleans, Louisiana	CI
04/09/19	ACell, Inc. and Southmedic Announce Canadian Launch of Gentrix Surgical Matrix Family of Products	CI
08/04/19	ACell, Inc. Enters into Exclusive Long-Term Product Supply and Distribution Agreement with First Horizon, LLC and Weihai Jierui Medical Products Co., Ltd	CI
15/10/18	ACell, Inc. and Southmedic Announce Canadian Launch of Cytal Wound Matrix and MicroMatrix	CI
08/10/18	ACell's Gentrix Surgical Matrix Provides Exceptional Long-Term Results in Complex Patient Populations for Durable Reinforcement of Ventral Hernias	CI
20/07/18	ACell to Host Grand Opening and Ribbon Cutting for Medical Learning Center	CI
08/05/18	ACell, Inc. Names Nino Pionati as Vice President, International and Business Development	CI
11/04/18	ACell, Inc. Announces Launch of Gentrix® Incisional	CI

Manager	Title	Age	Since
Matthew R. Kunst DFI	Director of Finance/CFO	-	01/01/2020
Patty Meehan ADM	Chief Administrative Officer	-	01/01/2002
Jim Kuras CTO	Chief Tech/Sci/R&D Officer	-	01/01/2020

Director	Title	Age	Since
John J. McDonnell BRD	Director/Board Member	59	-
Martin Pfinsgraff BRD	Director/Board Member	71	01/07/2019
Kyle C. Kerbawy CHM	Chairman	79	01/08/2015

ACell, Inc. Stock

Stocks

ACLL

US00444J1025

Medical Equipment, Supplies & Distribution

Latest news : ACell, Inc.

News in other languages: ACell, Inc.

Managers and Directors: ACell, Inc.

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ACELL, INC.	-.--%	-.--%	-	-	340M
ABBOTT LABORATORIES	+2.66%	+2.76%	-17.65%	-9.74%	175B
MEDTRONIC PLC	+1.41%	-0.04%	-9.91%	-6.30%	105B
CENCORA, INC.	+0.81%	+0.03%	+6.04%	+60.88%	59.35B
HOYA CORPORATION	-1.13%	-1.96%	+32.11%	+56.38%	50.71B
BECTON, DICKINSON AND COMPANY	+1.82%	-1.44%	-15.11%	-44.32%	42.15B
MEDLINE INC.	+3.36%	-2.20%	-	-	31.82B
DEXCOM, INC.	+1.38%	-6.91%	-17.74%	-44.14%	27.2B
WEST PHARMACEUTICAL SERVICES, INC.	-5.19%	-5.40%	+21.43%	-9.88%	25.11B
STERIS PLC	+1.68%	-1.68%	-5.75%	-7.74%	20.53B
Average	+0.66%	-3.08%	-0.82%	-0.61%	53.77B
Weighted average by Cap.	+1.34%	-1.51%	-5.64%	+1.24%

	2018	2019
Net sales	89.22M 78.36M 72.88M 66.87M 126M 8.59B 128M 865M 338M 4.22B 335M 328M 14.61B	101M 88.53M 82.33M 75.55M 142M 9.71B 144M 978M 382M 4.77B 378M 370M 16.5B
Net income	-3.13M -2.75M -2.56M -2.35M -4.41M -302M -4.48M -30.37M -11.87M -148M -11.76M -11.5M -513M	1.45M 1.27M 1.18M 1.09M 2.04M 140M 2.07M 14.05M 5.49M 68.59M 5.44M 5.32M 237M
Net Debt	-	-